Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
17.12
-0.08 (-0.47%)
Jun 8, 2026, 4:00 PM EDT - Market closed
AAPG Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 574.12 | 980.65 | 221.98 | 209.71 | 27.91 | |
Revenue Growth (YoY) | -41.45% | 341.77% | 5.85% | 651.38% | 124.18% |
Cost of Revenue | 48.94 | 29.09 | 30.54 | 22 | 3.33 |
Gross Profit | 525.18 | 951.57 | 191.44 | 187.71 | 24.58 |
Selling, General & Admin | 599.92 | 383.12 | 376.46 | 328.02 | 191.26 |
Research & Development | 1,137 | 947.25 | 706.97 | 743.1 | 766.49 |
Other Operating Expenses | 73.6 | 9.08 | 5.2 | 17.67 | 50.4 |
Total Operating Expenses | 1,811 | 1,339 | 1,089 | 1,089 | 1,008 |
Operating Income | -1,286 | -387.88 | -897.2 | -901.08 | -983.57 |
Interest Income | 0.31 | -0.28 | 1.08 | -0.28 | - |
Interest Expense | -54.07 | -64.46 | -96.06 | -52.79 | -16.73 |
Other Non-Operating Income (Expense) | 103.5 | 57.36 | 59.32 | 66.97 | 168.06 |
Total Non-Operating Income (Expense) | 49.74 | -7.38 | -35.67 | 13.91 | 151.33 |
Pretax Income | -1,236 | -395.26 | -932.86 | -887.17 | -832.25 |
Provision for Income Taxes | 6.94 | 10.43 | -7.15 | -4.25 | -49.83 |
Net Income | -1,243 | -405.68 | -925.71 | -882.92 | -782.42 |
Minority Interest in Earnings | -0.22 | -0.25 | -0.08 | - | - |
Net Income to Common | -1,243 | -405.43 | -925.64 | -882.92 | -782.42 |
Shares Outstanding (Basic) | 89 | 76 | 71 | 66 | 64 |
Shares Outstanding (Diluted) | 89 | 76 | 71 | 66 | 64 |
Shares Change (YoY) | 17.90% | 7.00% | 7.06% | 3.56% | 17.93% |
EPS (Basic) | -13.96 | -5.36 | -13.12 | -13.40 | -12.28 |
EPS (Diluted) | -13.96 | -5.36 | -13.12 | -13.40 | -12.28 |
Shares Outstanding | 93.33 | 78.81 | 72.55 | 65.97 | 65.72 |
Free Cash Flow | -1,202 | -135.65 | -772.19 | -857.2 | -1,036 |
Free Cash Flow Per Share | -13.50 | -1.80 | -10.94 | -13.00 | -16.28 |
Gross Margin | 91.48% | 97.03% | 86.24% | 89.51% | 88.08% |
Operating Margin | -223.96% | -39.55% | -404.17% | -429.68% | -3524.09% |
Profit Margin | -216.50% | -41.37% | -417.02% | -421.02% | -2803.38% |
FCF Margin | -209.31% | -13.83% | -347.86% | -408.75% | -3712.82% |
EBITDA | -1,199 | -294.71 | -804 | -838.17 | -955.25 |
EBITDA Margin | -208.90% | -30.05% | -362.19% | -399.68% | -3422.60% |
EBIT | -1,286 | -387.88 | -897.2 | -901.08 | -983.57 |
EBIT Margin | -223.96% | -39.55% | -404.17% | -429.68% | -3524.09% |
Effective Tax Rate | -0.56% | -2.64% | 0.77% | 0.48% | 5.99% |